Overview

Iron in Patients With Cardiovascular Disease

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
It is now recognized that iron deficiency in cardiovascular disease contributes to impaired clinical outcome.
Phase:
Phase 3
Details
Lead Sponsor:
Dr. med. Mahir Karakas
Treatments:
Ferric Compounds
Iron